NERLYNX

knight therapeutics inc.🇨🇦 Health Canada

Approval Id: 56f606fa9987775d
Drug Approval Canada Name: NERLYNX
Product Name: NERLYNX
Status: Marketed
Status Date: 2019-12-20
Original Market Date: 2019-12-20
Din: 02490536
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EH02 NERATINIB
Atc Name: l 01 eh 02
Aig Number: 0161650001
Company Name: knight therapeutics inc.
Company Address: 1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8

NERATINIB (NERATINIB MALEATE)

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

56f606fa9987775d

Type

Standard